Research scientists at several national and international institutions are engaged in ongoing scientific collaborations with the NeuroHIV Cure Consortium.
Collaborators
Victor Valcour, MD, PhD
Dr. Valcour, a Founding Director of INHCC, alongside Dr Ananworanich, is a Professor of Medicine with a shared appointment in the Division of Geriatric Medicine and the Department of Neurology at the University of California-San Francisco. He is also Deputy Director of SEARCH/Thailand operating research in acute HIV, pediatric HIV, and markers of dementia in chronic HIV. In Africa, he has partnered with the MHRP to survey cognitive disorders among HIV-infected individuals in Nigeria, Uganda, Kenya, and Tanzania. Dr. Valcour is actively engaged in mentoring individuals wishing to become independent clinical researchers. His research portfolio provides a broad array of local and international projects that can serve as resources for mentored projects. Dr. Valcour serves as an Executive Committee member of the AIDS Research Institute (ARI).
Dr. Valcour, a Founding Director of INHCC, alongside Dr Ananworanich, is a Professor of Medicine with a shared appointment in the Division of Geriatric Medicine and the Department of Neurology at the University of California-San Francisco. He is also Deputy Director of SEARCH/Thailand operating research in acute HIV, pediatric HIV, and markers of dementia in chronic HIV. In Africa, he has partnered with the MHRP to survey cognitive disorders among HIV-infected individuals in Nigeria, Uganda, Kenya, and Tanzania. Dr. Valcour is actively engaged in mentoring individuals wishing to become independent clinical researchers. His research portfolio provides a broad array of local and international projects that can serve as resources for mentored projects. Dr. Valcour serves as an Executive Committee member of the AIDS Research Institute (ARI).
Jintanat Ananworanich, MD, PhD
Dr Ananworanich, is a Founding Director of INHCC, alongside Dr Valcour. She is the Clinical Development Leader at the Bill & Melinda Gates Medical Research Institute (Gates MRI). She was previously Associate Director for Therapeutics Research for the US Military HIV Research Program and Co-Director of SEARCH at the Thai Red Cross AIDS Research Center in Bangkok. She is Professor of Medicine at the Department of Global Health, the University of Amsterdam and Professor of Pediatrics at the University of Maryland School of Medicine. For the past two decades, she has led over 100 HIV clinical studies and published more than 250 articles in peer-reviewed journals. Her research interests are in acute HIV infection, HIV cure and HIV-associated neurocognition. She is protocol chair of several studies evaluating early treatment and immune interventions aimed at achieving HIV remission in adults and children living with HIV.
Dr Ananworanich, is a Founding Director of INHCC, alongside Dr Valcour. She is the Clinical Development Leader at the Bill & Melinda Gates Medical Research Institute (Gates MRI). She was previously Associate Director for Therapeutics Research for the US Military HIV Research Program and Co-Director of SEARCH at the Thai Red Cross AIDS Research Center in Bangkok. She is Professor of Medicine at the Department of Global Health, the University of Amsterdam and Professor of Pediatrics at the University of Maryland School of Medicine. For the past two decades, she has led over 100 HIV clinical studies and published more than 250 articles in peer-reviewed journals. Her research interests are in acute HIV infection, HIV cure and HIV-associated neurocognition. She is protocol chair of several studies evaluating early treatment and immune interventions aimed at achieving HIV remission in adults and children living with HIV.
Sandyha (Sandy) Vasan, MD
Dr. Vasan serves as Director of the HJF component of the US Military HIV Research Program (MHRP) and Emerging Infectious Disease Branch (EIDB) at the Walter Reed Army Institute of Research and is a former director of the INHCC. Dr. Vasan obtained her undergraduate degree in mechanical engineering at the Massachusetts Institute of Technology before completing her MD at the Harvard-MIT Division of Health Sciences and Technology at Harvard Medical School. Dr. Vasan recently served as MHRP’s Associate Director for HIV Vaccine Research, and prior to that she served MHRP at AFRIMS in Bangkok for seven years as Science Director and head of the Nonhuman Primate Laboratory. At AFRIMS, she conducted preventive vaccine trials in follow-up to the RV144 HIV vaccine clinical trial.
Dr. Vasan serves as Director of the HJF component of the US Military HIV Research Program (MHRP) and Emerging Infectious Disease Branch (EIDB) at the Walter Reed Army Institute of Research and is a former director of the INHCC. Dr. Vasan obtained her undergraduate degree in mechanical engineering at the Massachusetts Institute of Technology before completing her MD at the Harvard-MIT Division of Health Sciences and Technology at Harvard Medical School. Dr. Vasan recently served as MHRP’s Associate Director for HIV Vaccine Research, and prior to that she served MHRP at AFRIMS in Bangkok for seven years as Science Director and head of the Nonhuman Primate Laboratory. At AFRIMS, she conducted preventive vaccine trials in follow-up to the RV144 HIV vaccine clinical trial.
Lishomwa (Lish) C. Ndhlovu, MD, PhD
Dr. Ndhlovu, an American Society of Microbiology Fellow, is a Professor of Immunology and Director of the HIV Immunopathogenesis Laboratory in the Department of Medicine, Division of Infectious Diseases at Weill Cornell Medicine (WCM) and a faculty member of the WCM Cardiovascular Research Institute in New York. After completing medical training, his scientific career began at Tohoku University in Japan where he received his PhD in Immunology and pursued post-doctoral training at the University of California-San Francisco, as an Irvington Institute Fellow of the Cancer Research Institute. The Ndhlovu Laboratory has specific interests in pioneering discoveries for achieving a cure for HIV and strives to promote research methods in disadvantaged settings with ongoing studies in Myanmar, Thailand and across Africa. He has served in multiple editorial roles including being the current Co-Editor in Chief of the journal AIDS Research and Human Retroviruses.
Dr. Ndhlovu, an American Society of Microbiology Fellow, is a Professor of Immunology and Director of the HIV Immunopathogenesis Laboratory in the Department of Medicine, Division of Infectious Diseases at Weill Cornell Medicine (WCM) and a faculty member of the WCM Cardiovascular Research Institute in New York. After completing medical training, his scientific career began at Tohoku University in Japan where he received his PhD in Immunology and pursued post-doctoral training at the University of California-San Francisco, as an Irvington Institute Fellow of the Cancer Research Institute. The Ndhlovu Laboratory has specific interests in pioneering discoveries for achieving a cure for HIV and strives to promote research methods in disadvantaged settings with ongoing studies in Myanmar, Thailand and across Africa. He has served in multiple editorial roles including being the current Co-Editor in Chief of the journal AIDS Research and Human Retroviruses.
Lydie Trautmann, PhD
Dr. Trautmann is an Associate Professor at the Vaccine and Gene Therapy Institute (VGTI) at Oregon Health & Science University. With an MSc from L Pasteur University and an Engineering degree from ESBS in Strasbourg, she obtained her PhD in Immunology at Paris V in 2003, followed by post-doctoral training at Univ of Montreal, 2004-2009. She was an Associate Member at VGTI of Florida before becoming Chief of Cellular Immunology at MHRP, 2015-2019.. Dr. Trautmann's lab uses a variety of unique cell-based assays, including human/simian primary T cell culture, expansion and cloning, TCR repertoire sequencing, advanced flow cytometry analysis, and functional assays to measure immune functions that are key in immunological processes.
Dr. Trautmann is an Associate Professor at the Vaccine and Gene Therapy Institute (VGTI) at Oregon Health & Science University. With an MSc from L Pasteur University and an Engineering degree from ESBS in Strasbourg, she obtained her PhD in Immunology at Paris V in 2003, followed by post-doctoral training at Univ of Montreal, 2004-2009. She was an Associate Member at VGTI of Florida before becoming Chief of Cellular Immunology at MHRP, 2015-2019.. Dr. Trautmann's lab uses a variety of unique cell-based assays, including human/simian primary T cell culture, expansion and cloning, TCR repertoire sequencing, advanced flow cytometry analysis, and functional assays to measure immune functions that are key in immunological processes.
Robert Paul, PhD
Dr Robert Paul serves as Executive Director of the Missouri Institute of Mental Health and and is a Professor of Psychological Sciences at the University of Missouri-St Louis. Dr Paul earned his PhD in Biological Psychology from the University of Oklahoma Health Science Center and completed his internship and postdoctoral fellowship in Neuropsychology at Brown Medical School. Dr. Paul’s research team has developed specific expertise in HIV, subcortical stroke, and early life trauma, three conditions that impact the integrity of deep brain structures including: white matter, basal ganglia, and limbic structures. Investigations include leveraging innovative neuroinformatic models and artificial intelligence (AI) to discover latent, clinically relevant structure and meaning within large and complex data matrices. Dr. Paul has a special interest in the application of these methods in resource-limited environments and has active research programs in South Africa, Thailand, Vietnam, and Cambodia.
Dr Robert Paul serves as Executive Director of the Missouri Institute of Mental Health and and is a Professor of Psychological Sciences at the University of Missouri-St Louis. Dr Paul earned his PhD in Biological Psychology from the University of Oklahoma Health Science Center and completed his internship and postdoctoral fellowship in Neuropsychology at Brown Medical School. Dr. Paul’s research team has developed specific expertise in HIV, subcortical stroke, and early life trauma, three conditions that impact the integrity of deep brain structures including: white matter, basal ganglia, and limbic structures. Investigations include leveraging innovative neuroinformatic models and artificial intelligence (AI) to discover latent, clinically relevant structure and meaning within large and complex data matrices. Dr. Paul has a special interest in the application of these methods in resource-limited environments and has active research programs in South Africa, Thailand, Vietnam, and Cambodia.
Diane Bolton, PhD
Dr Diane Bolton is Chief, Animal Models and Pathogenesis at the US Military HIV Research Program (MHRP) located at the Walter Reed Army Institute of Research in Silver Spring, MD. She earned her PhD though the Johns Hopkins University-NIH cooperative graduate program and her postdoctoral fellowship with Dr Mario Roederer at NIH’s Vaccine Research Center in Bethesda, MD. Dr. Bolton’s interests focus on immune responses to vaccination and mechanisms of viral persistence during HIV/SIV infection. Her team explores the adaptive immune responses to prophylactic and therapeutic vaccine regimens to elucidate cellular and humoral correlates of protection.
Dr Diane Bolton is Chief, Animal Models and Pathogenesis at the US Military HIV Research Program (MHRP) located at the Walter Reed Army Institute of Research in Silver Spring, MD. She earned her PhD though the Johns Hopkins University-NIH cooperative graduate program and her postdoctoral fellowship with Dr Mario Roederer at NIH’s Vaccine Research Center in Bethesda, MD. Dr. Bolton’s interests focus on immune responses to vaccination and mechanisms of viral persistence during HIV/SIV infection. Her team explores the adaptive immune responses to prophylactic and therapeutic vaccine regimens to elucidate cellular and humoral correlates of protection.
Trevor Crowell, MD
Dr. Crowell is Associate Director of the Department of Epidemiology and Threat Assessment at MHRP, where he oversees cohorts and other epidemiologic studies of HIV, sexually transmitted infections, and other infectious disease threats to global public health and U.S. military force readiness. Dr. Crowell has published extensively on clinical outcomes among persons living with or at risk for HIV, with a focus on U.S. military service members, sexual and gender minority populations, elite controllers, and individuals diagnosed during acute HIV infection. His current research also includes clinical trials of novel interventions to achieve HIV remission as well as preventive vaccine candidates for HIV and other infectious diseases.
Dr. Crowell is Associate Director of the Department of Epidemiology and Threat Assessment at MHRP, where he oversees cohorts and other epidemiologic studies of HIV, sexually transmitted infections, and other infectious disease threats to global public health and U.S. military force readiness. Dr. Crowell has published extensively on clinical outcomes among persons living with or at risk for HIV, with a focus on U.S. military service members, sexual and gender minority populations, elite controllers, and individuals diagnosed during acute HIV infection. His current research also includes clinical trials of novel interventions to achieve HIV remission as well as preventive vaccine candidates for HIV and other infectious diseases.
Carlo Sacdalan, MD, MBA
Dr. Carlo Sacdalan is a Research Physician at the SEARCH at the Thai Red Cross AIDS Research Centre in Bangkok, Thailand. He is currently handling the acute HIV cohort (SEARCH010/RV254) and the comparator study, SEARCH013/RV304 . He is a published research physician with prior experience working for a clinical research organization. Dr. Sacdalan earned his dual degree of MD and MBA from the Ateneo School of Medicine and Public Health in Manila, Philippines. He is currently pursuing a MSc in Public Health from the University of London, London School of Hygiene and Tropical Medicine.
Dr. Carlo Sacdalan is a Research Physician at the SEARCH at the Thai Red Cross AIDS Research Centre in Bangkok, Thailand. He is currently handling the acute HIV cohort (SEARCH010/RV254) and the comparator study, SEARCH013/RV304 . He is a published research physician with prior experience working for a clinical research organization. Dr. Sacdalan earned his dual degree of MD and MBA from the Ateneo School of Medicine and Public Health in Manila, Philippines. He is currently pursuing a MSc in Public Health from the University of London, London School of Hygiene and Tropical Medicine.
Napapon Sailasuta, PhD
Dr. Sailasuta is a California Institute of Technology graduate. She worked for General Electric HealthCare for 15 years in the Research and Development division and has over 20 years of research and development in magnetic resonance spectroscopy and imaging methods. Dr. Sailasuta's primary research interest is to understand the mechanisms of glia dysfunction in HIV infection and addiction as well as neurodegerative diseases using the noninvasive multi-modalities magnetic resonance approaches. Dr. Sailasuta has developed several proton magnetic resonance spectroscopy methods to directly quantify several difficult-to-measure brain chemicals.
Dr. Sailasuta is a California Institute of Technology graduate. She worked for General Electric HealthCare for 15 years in the Research and Development division and has over 20 years of research and development in magnetic resonance spectroscopy and imaging methods. Dr. Sailasuta's primary research interest is to understand the mechanisms of glia dysfunction in HIV infection and addiction as well as neurodegerative diseases using the noninvasive multi-modalities magnetic resonance approaches. Dr. Sailasuta has developed several proton magnetic resonance spectroscopy methods to directly quantify several difficult-to-measure brain chemicals.
Donn Colby, MD, MPH
Dr. Donn Colby has dedicated most of his career to HIV prevention and treatment in Southeast Asia. He recently returned to the US, joining MHRP, after 18 years of living and working in Vietnam and Thailand. While at the Thai Red Cross AIDS Research Center, he led multiple clinical trials to investigate new treatment methods with the goal of inducing a remission or cure of HIV infection, including innovative trials of monoclonal antibodies and therapeutic vaccines. Donn’s research collaborations have also shed light on antiretroviral drug resistance and its effect on the future of HIV prevention and treatment, as well as on the safety and efficacy of pre-exposure prophylaxis (PrEP), a daily pill for HIV prevention. As part of this effort, he set up the first publicly accessible clinic for provision of PrEP in Asia.
Dr. Donn Colby has dedicated most of his career to HIV prevention and treatment in Southeast Asia. He recently returned to the US, joining MHRP, after 18 years of living and working in Vietnam and Thailand. While at the Thai Red Cross AIDS Research Center, he led multiple clinical trials to investigate new treatment methods with the goal of inducing a remission or cure of HIV infection, including innovative trials of monoclonal antibodies and therapeutic vaccines. Donn’s research collaborations have also shed light on antiretroviral drug resistance and its effect on the future of HIV prevention and treatment, as well as on the safety and efficacy of pre-exposure prophylaxis (PrEP), a daily pill for HIV prevention. As part of this effort, he set up the first publicly accessible clinic for provision of PrEP in Asia.
Michael Corley, PhD, MA
Dr. Corley is an Assistant Professor in Medicine at the Division of Infectious Diseases at Weill Cornell Medicine. He received a MA and PhD in Behavioral Neuroscience from the University of Hawaii and completed postdoctoral training in epigenetics, health disparities, immunology, and infectious disease. Dr. Corley’s research focuses on better understanding host epigenetic mechanisms in immune cells reprogrammed by HIV infection and investigating how an individual’s unique epigenetic signature predicts innate and adaptive immune cell responses and longitudinal brain health outcomes following HIV exposure. His laboratory is also dedicated to utilizing cutting-edge “omics” technologies to increase knowledge towards addressing health inequalities and infectious disease.
Dr. Corley is an Assistant Professor in Medicine at the Division of Infectious Diseases at Weill Cornell Medicine. He received a MA and PhD in Behavioral Neuroscience from the University of Hawaii and completed postdoctoral training in epigenetics, health disparities, immunology, and infectious disease. Dr. Corley’s research focuses on better understanding host epigenetic mechanisms in immune cells reprogrammed by HIV infection and investigating how an individual’s unique epigenetic signature predicts innate and adaptive immune cell responses and longitudinal brain health outcomes following HIV exposure. His laboratory is also dedicated to utilizing cutting-edge “omics” technologies to increase knowledge towards addressing health inequalities and infectious disease.
Phillip Chan, MD
Phillip Chan is a neurologist by training. After graduation from the medical school of the Chinese University of Hong Kong, he completed his fellowships in internal medicine and Neurology at the Queen Elizabeth Hospital of Hong Kong. In 2015, he joined SEARCH at the Institute of HIV Research and Innovation (IHRI) in Thailand and has been working for NeuroHIV projects affiliated with the US Military HIV Research Program, UCSF and Yale University. Apart from his interest in neuroinfectious diseases, he also works with the Hong Kong University of Science and Technology for neurodegenerative disease research projects since 2018.
Phillip Chan is a neurologist by training. After graduation from the medical school of the Chinese University of Hong Kong, he completed his fellowships in internal medicine and Neurology at the Queen Elizabeth Hospital of Hong Kong. In 2015, he joined SEARCH at the Institute of HIV Research and Innovation (IHRI) in Thailand and has been working for NeuroHIV projects affiliated with the US Military HIV Research Program, UCSF and Yale University. Apart from his interest in neuroinfectious diseases, he also works with the Hong Kong University of Science and Technology for neurodegenerative disease research projects since 2018.
Shelly J. Krebs, PhD
Dr. Krebs is a Scientist and Principal Investigator at the U.S. Military HIV Research Program (MHRP) located at the Walter Reed Army Institute of Research. She earned her PhD at Dartmouth Medical School and was a postdoctoral fellow at the Centers of Disease Control and Association of Public Health Laboratories, as well as at the Vaccine and Gene Therapy Institute. She joined MHRP in 2012 to study the development of HIV-specific B cell responses and immune activation in HIV infection and vaccination. A major goal of the Krebs laboratory is to further understand how HIV infected individuals naturally develop potent antibody responses to be able to exploit these characteristics in the design of HIV immunogens.
Dr. Krebs is a Scientist and Principal Investigator at the U.S. Military HIV Research Program (MHRP) located at the Walter Reed Army Institute of Research. She earned her PhD at Dartmouth Medical School and was a postdoctoral fellow at the Centers of Disease Control and Association of Public Health Laboratories, as well as at the Vaccine and Gene Therapy Institute. She joined MHRP in 2012 to study the development of HIV-specific B cell responses and immune activation in HIV infection and vaccination. A major goal of the Krebs laboratory is to further understand how HIV infected individuals naturally develop potent antibody responses to be able to exploit these characteristics in the design of HIV immunogens.
Nittaya Phanuphak, MD, PhD
Nittaya Phanuphak is the Executive Director of the Institute of HIV Research and Innovation (IHRI) and Chief of SEARCH in Bangkok, Thailand. She started her career in the HIV field in 2002 by leading a nationwide prevention of mother-to-child transmission operational study which resulted in Thai guidelines allowing the use of three-drug antiretroviral regimens for pregnant women in 2010. Nittaya has a deep interest in Key Population-Led Health Services (KPLHS). KPLHS approaches empower lay providers who are members of KP communities to perform HIV/STI testing and dispense PrEP/PEP, antiretroviral treatment and STI treatment to their peers. Dr. Nittaya has more than 60 publications in peer-reviewed journals.
Nittaya Phanuphak is the Executive Director of the Institute of HIV Research and Innovation (IHRI) and Chief of SEARCH in Bangkok, Thailand. She started her career in the HIV field in 2002 by leading a nationwide prevention of mother-to-child transmission operational study which resulted in Thai guidelines allowing the use of three-drug antiretroviral regimens for pregnant women in 2010. Nittaya has a deep interest in Key Population-Led Health Services (KPLHS). KPLHS approaches empower lay providers who are members of KP communities to perform HIV/STI testing and dispense PrEP/PEP, antiretroviral treatment and STI treatment to their peers. Dr. Nittaya has more than 60 publications in peer-reviewed journals.
Eugene Kroon, MD
Eugène Kroon, recently retired, was the Medical Doctor Supervisor at the IHRI, based in Bangkok. He started his career in clinical HIV research in Amsterdam in 1994 under Professor Joep Lange and has mostly worked in Thailand since 1996. The focus of his early HIV research was in new antiretroviral therapies and access to effective ART in Thailand and in emerging economies. This research contributed to marketing authorization of drugs such as nevirapine and ritonavir and also contributed to the Thai government’s decision, in the early 2000s, to expand access to ART. He also contributed to rolling out ART with the Clinton HIV-AIDS Initiative in South-Africa. His current work focuses on describing acute HIV infection and on HIV cure strategies. The RV254 study has already provided valuable insights regarding the former while this cohort of virally suppressed acutely infected subjects are now participating in HIV functional cure studies at IHRI.
Eugène Kroon, recently retired, was the Medical Doctor Supervisor at the IHRI, based in Bangkok. He started his career in clinical HIV research in Amsterdam in 1994 under Professor Joep Lange and has mostly worked in Thailand since 1996. The focus of his early HIV research was in new antiretroviral therapies and access to effective ART in Thailand and in emerging economies. This research contributed to marketing authorization of drugs such as nevirapine and ritonavir and also contributed to the Thai government’s decision, in the early 2000s, to expand access to ART. He also contributed to rolling out ART with the Clinton HIV-AIDS Initiative in South-Africa. His current work focuses on describing acute HIV infection and on HIV cure strategies. The RV254 study has already provided valuable insights regarding the former while this cohort of virally suppressed acutely infected subjects are now participating in HIV functional cure studies at IHRI.
Adam W Carrico, PhD
Dr Carrico is a University of Miami Professor of Public Health Services and a clinical-health psychologist pursuing a translational research program to elucidate the biological pathways whereby substance use may amplify risk for HIV acquisition, clinical HIV progression, and SARS-CoV-2 infection. His team was among the first to document stimulant-associated alterations in immune activation, inflammation, and HIV persistence in those with treated HIV infection. Dr. Carrico’s laboratory is actively pursuing bio-behavioral studies to examine whether and how stimulant use as well as other behavioral factors alter DNA methylation, the rectal microbiome, and rectal immune dysregulation in sexual minority males living with or at risk for HIV.
Dr Carrico is a University of Miami Professor of Public Health Services and a clinical-health psychologist pursuing a translational research program to elucidate the biological pathways whereby substance use may amplify risk for HIV acquisition, clinical HIV progression, and SARS-CoV-2 infection. His team was among the first to document stimulant-associated alterations in immune activation, inflammation, and HIV persistence in those with treated HIV infection. Dr. Carrico’s laboratory is actively pursuing bio-behavioral studies to examine whether and how stimulant use as well as other behavioral factors alter DNA methylation, the rectal microbiome, and rectal immune dysregulation in sexual minority males living with or at risk for HIV.
Alexandra Schuetz, PhD
Dr. Schuetz currently serves as Chief of Cellular Immunology the Armed Forces Research Institute of Medical Sciences (AFRIMS) in Thailand. She received her PhD in 2004 from the University of Saarland, Germany, in collaboration with Bayer HealthCare AG, After working at the Fraunhofer Institute for Biomedical Engineering, she joined MHRP in 2006 and relocated to Mbeya, Tanzania, serving as Head of Immunology and Specimen Processing. .In 2008, she relocated to Bangkok, Thailand, to continue work for MHRP and is since then involved in research on acute HIV infection, cure studies and HIV vaccine trials. Her lab is interested in understanding the mechanisms by which HIV infection causes dysfunction of the gastrointestinal and reproductive tracts and the lymphoid immune systems.
Dr. Schuetz currently serves as Chief of Cellular Immunology the Armed Forces Research Institute of Medical Sciences (AFRIMS) in Thailand. She received her PhD in 2004 from the University of Saarland, Germany, in collaboration with Bayer HealthCare AG, After working at the Fraunhofer Institute for Biomedical Engineering, she joined MHRP in 2006 and relocated to Mbeya, Tanzania, serving as Head of Immunology and Specimen Processing. .In 2008, she relocated to Bangkok, Thailand, to continue work for MHRP and is since then involved in research on acute HIV infection, cure studies and HIV vaccine trials. Her lab is interested in understanding the mechanisms by which HIV infection causes dysfunction of the gastrointestinal and reproductive tracts and the lymphoid immune systems.
Bonnie Slike, MS
Ms. Slike is a Senior Research Associate for the Henry M. Jackson Foundation in support of the U.S. Military HIV Research Program (MHRP) located at Walter Reed Army Institute for Research. She joined MHRP in 2005 and has over 20 years of research experience in the areas of cell biology, immunology and HIV. Since 2012, she has been a part of the B Cell Biology Core lead by Dr. Shelly Krebs. Her work focusses on two primary areas: investigation of the role of soluble immune factors in HIV infection and pathogenesis, and characterization of binding antibodies elicited following vaccination or infection.
Ms. Slike is a Senior Research Associate for the Henry M. Jackson Foundation in support of the U.S. Military HIV Research Program (MHRP) located at Walter Reed Army Institute for Research. She joined MHRP in 2005 and has over 20 years of research experience in the areas of cell biology, immunology and HIV. Since 2012, she has been a part of the B Cell Biology Core lead by Dr. Shelly Krebs. Her work focusses on two primary areas: investigation of the role of soluble immune factors in HIV infection and pathogenesis, and characterization of binding antibodies elicited following vaccination or infection.
Caroline Subra, PhD
Dr. Subra is a Scientist at Henry Jackson Foundation. She obtained her PhD in Cellular Biology and Biochemistry at the University of Toulouse, France, in 2010. Dr Subra performed post-doctoral training studying exosome implication in HIV pathogenesis at the Laval University in Quebec City, Canada. She joined Dr. Trautmann’s MHRP laboratory, in 2016, to study the cellular immune response to HIV infection and assess the implication of exosomes in acute HIV infection and in modulating the immune response. Her research interests include the cellular immune response to AHI in the CNS to decipher the mechanisms leading to neuroHIV.
Dr. Subra is a Scientist at Henry Jackson Foundation. She obtained her PhD in Cellular Biology and Biochemistry at the University of Toulouse, France, in 2010. Dr Subra performed post-doctoral training studying exosome implication in HIV pathogenesis at the Laval University in Quebec City, Canada. She joined Dr. Trautmann’s MHRP laboratory, in 2016, to study the cellular immune response to HIV infection and assess the implication of exosomes in acute HIV infection and in modulating the immune response. Her research interests include the cellular immune response to AHI in the CNS to decipher the mechanisms leading to neuroHIV.
Kalpana J. Kallianpur, PhD
Dr. Kallianpur holds a PhD in physics from the University of Texas at Austin and an MS in Biomedical Sciences from the University of Hawaii. Dr. Kallianpur’s research interests include the use of magnetic resonance imaging (MRI) to study the effects of HIV on brain structure and function. She has demonstrated associations between brain atrophy and the peripheral HIV DNA reservoir. Dr. Kallianpur joined the Hawaii Center for AIDS in 2008 and the Department of Tropical Medicine in 2016. In the SEARCH 011 study of chronic HIV infection and in prior work, Dr. Kallianpur used structural MRI to examine associations between peripheral HIV DNA reservoirs and brain injury.
Dr. Kallianpur holds a PhD in physics from the University of Texas at Austin and an MS in Biomedical Sciences from the University of Hawaii. Dr. Kallianpur’s research interests include the use of magnetic resonance imaging (MRI) to study the effects of HIV on brain structure and function. She has demonstrated associations between brain atrophy and the peripheral HIV DNA reservoir. Dr. Kallianpur joined the Hawaii Center for AIDS in 2008 and the Department of Tropical Medicine in 2016. In the SEARCH 011 study of chronic HIV infection and in prior work, Dr. Kallianpur used structural MRI to examine associations between peripheral HIV DNA reservoirs and brain injury.
Linda Jagodzinski, PhD
Dr. Jagodzinski is the Chief, Technology Assessment Lab for Walter Reed Army Institute (WRAIR), and provides molecular testing support to clinical research studies and to the HIV Diagnostics and Reference Laboratory in the diagnosis and monitoring of HIV-1 infected individuals. She has directed and collaborated on numerous studies of HIV-1 pathogenesis, molecular epidemiology, diagnosis and patient monitoring for 35 years.
Dr. Jagodzinski is the Chief, Technology Assessment Lab for Walter Reed Army Institute (WRAIR), and provides molecular testing support to clinical research studies and to the HIV Diagnostics and Reference Laboratory in the diagnosis and monitoring of HIV-1 infected individuals. She has directed and collaborated on numerous studies of HIV-1 pathogenesis, molecular epidemiology, diagnosis and patient monitoring for 35 years.
Holly Peay, PhD, MS
Holly Peay is a Senior Research Public Health Analyst at RTI International. She is a trained in bioethics, genetic counseling and social science. Her research areas of interest are decision making, decision support, quantification of patient and caregiver preferences, and disorder-specific adaptation. She has experience using multiple social science and health economic techniques, both well established and innovative, to explore needs, preferences, experiences, coping and adaptation, risk perception, and decision making.
Holly Peay is a Senior Research Public Health Analyst at RTI International. She is a trained in bioethics, genetic counseling and social science. Her research areas of interest are decision making, decision support, quantification of patient and caregiver preferences, and disorder-specific adaptation. She has experience using multiple social science and health economic techniques, both well established and innovative, to explore needs, preferences, experiences, coping and adaptation, risk perception, and decision making.
Gail Henderson, PhD
Dr Henderson is a professor of Social Medicine in the School of Medicine and adjunct professor of Sociology at the University of North Carolina at Chapel Hill. She was Department Chair from 2009 to 2015, Director of the UNC Center for Genomics and Society (CGS) from 2007-2019, and co-Director of the Center for AIDS Research (CFAR) International Core from 2004-2014. Dr Henderson was the Ethical, Legal and Social Implications (ELSI) Editor of the journal, Genetics in Medicine, from 2009-2017, and a Member of the National Human Genome Research Institute (NHGRI) Advisory Council from 2016-2020.
Dr Henderson is a professor of Social Medicine in the School of Medicine and adjunct professor of Sociology at the University of North Carolina at Chapel Hill. She was Department Chair from 2009 to 2015, Director of the UNC Center for Genomics and Society (CGS) from 2007-2019, and co-Director of the Center for AIDS Research (CFAR) International Core from 2004-2014. Dr Henderson was the Ethical, Legal and Social Implications (ELSI) Editor of the journal, Genetics in Medicine, from 2009-2017, and a Member of the National Human Genome Research Institute (NHGRI) Advisory Council from 2016-2020.
The following institutions are involved in ongoing scientific collaborations with the INHCC:
- U.S. Military HIV Research Program (MHRP), Bethesda, MD
- Henry M. Jackson Foundation (HJF), Bethesda, MD
- Walter Reed Army Institute of Research (WRAIR), Rockville, MD
- Armed Forces Research Institute of Medical Sciences (AFRIMS), Thailand and US
- Southeast Asia Research Collaboration with Hawaii (SEARCH), Bangkok, Thailand
- Institute of HIV Research and Innovation (IHRI), Bangkok, Thailand
- Chulalongkorn University, Bangkok, Thailand
- Thai Red Cross AIDS Research Centre (TRCARC), Bangkok, Thailand
